首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1970959

家禽診斷市場－全球產業規模、佔有率、趨勢、機會、預測：按檢測類型、疾病類型、地區和競爭格局分類，2021-2031年

Poultry Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type, By Disease Type, By Region & Competition, 2021-2031F

出版日期: 2026年01月19日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球家禽診斷市場預計將從 2025 年的 5.341 億美元成長到 2031 年的 8.9623 億美元，複合年成長率達到 9.01%。

此領域涵蓋用於檢測病原體和監測禽類健康的專用試劑、檢測套組和設備。全球對動物性蛋白質的需求不斷成長是推動該領域發展的主要因素，因此，嚴格的疾病監測對於維護食品安全和供應鏈穩定性至關重要。此外，跨國通用感染疾病的威脅日益加劇，迫使生產者實施嚴格的檢測通訊協定，以滿足國際貿易法規和動物福利標準。這些要求的規模龐大；例如，根據美國國家雞肉委員會的一份報告，到2024年，美國將生產超過94億隻肉雞，這凸顯了大規模養殖需要持續監測以預防疾病爆發。

市場概覽
預測期	2027-2031
市場規模：2025年	5.341億美元
市場規模：2031年	8.9623億美元
複合年成長率：2026-2031年	9.01%
成長最快的細分市場	酵素連結免疫吸附試驗
最大的市場	北美洲

儘管前景樂觀，但先進診斷技術相關的高昂營運成本構成了市場准入的重大障礙。對於發展中地區的小規模生產商而言，建造先進分子檢測基礎設施的經濟負擔往往超過其即時經濟效益。這種成本障礙造成了醫療服務取得的不平等，使全球疾病防治工作面臨風險。因此，這些資金限制可能會阻礙價格敏感型市場對診斷解決方案的採納和推廣，進而抑制這些地區的成長。

市場促進因素

全球禽肉和禽蛋消費量的不斷成長正在從根本上改變診斷格局，迫使生產商提高產量以滿足對價格合理的蛋白質的需求。這種快速擴張需要嚴格的健康監測通訊協定，以避免供應鏈中斷並確保家禽群的生產力。隨著養殖密度的增加，依賴診斷檢測對於維持禽群健康和最佳化產量至關重要。經合組織-糧農組織於2024年7月發布的《農業展望》預測，到2033年，全球禽肉消費量將達到1.6億噸，凸顯了生產商面臨的持續壓力。為了滿足這項需求，該產業繼續大規模運營，美國農業部2024年4月的預測顯示，全球禽肉年產量將達到1.033億噸，這將直接推動對診斷解決方案的需求。

同時，通用和禽類感染疾病的傳播是推動先進檢測技術應用的主要動力。病原體不僅威脅動物福利，還會造成嚴重的經濟損失，因此相關人員必須投資建造快速、準確的檢測基礎設施。有效的診斷技術是抵禦可能導致大規模撲殺和貿易限制的疾病爆發的第一道防線。其經濟影響巨大；根據美國國家醫學圖書館2024年的估計，光是球蟲這種寄生蟲病每年就造成24億至30億美元的損失。這些經濟風險凸顯了早期檢測技術的重要性，它有助於在疫情發展成區域性危機之前將其控制住。

市場挑戰

全球家禽診斷市場面臨巨大的成長障礙，這主要是由於自動化平台和先進分子檢測所需的高昂資本和營運成本。這些方法需要昂貴的設備、專用試劑和熟練的專業人員，對於中小型生產者而言，這構成了難以負擔的成本結構。在利潤率較低的新興經濟體，實施嚴格的檢測通訊協定的成本往往超過預期的即時收益，迫使養殖戶依賴準確性較低的傳統觀察方法，而不是投資先進的診斷工具。

這些經濟限制因素直接限制了診斷設備製造商的潛在市場規模，有效地阻礙了在潛在需求龐大的地區擴張。已開發國家普及率低意味著價格敏感地區的關鍵疾病控制需求無法滿足。跨境疾病的全球蔓延凸顯了這種機會損失的嚴重性。世界動物衛生組織（OIE）報告稱，2024年全球82個國家和地區爆發了高致病性禽流感疫情。儘管這些病原體廣泛流行，但高昂的基礎設施成本阻礙了受影響地區診斷市場實現相應的成長。

市場趨勢

將人工智慧融入疾病預測建模正在革新該領域，使重點從被動診斷轉向預防性健康管理。先進的演算法現在可以分析來自雞舍環境的連續資料流，例如飲水量和發聲的聲學特徵，在臨床症狀出現之前檢測到細微的生理異常。這項技術使生產者能夠比傳統方法提前數天進行干預，顯著降低疫情的嚴重性和對抗生素的依賴。例如，發表在2025年10月《WATTPoultry》雜誌上的報導報道，Optifarm的人工智慧驅動的飲水模式分析能夠以超過91%的準確率識別先天免疫系統反應，提供了一個無需新硬體的關鍵早期預警系統。

同時，隨著高致病性禽流感（HPAI）的流行，DIVA（感染動物與疫苗接種動物的區分）策略的採用正在加速。由於傳統的大規模撲殺在經濟上難以為繼，疫苗接種策略正在向疫苗接種方向轉變，而用於區分已接種疫苗禽類和野生病毒感染禽類的配套診斷方法對於維持其貿易合格至關重要。為了強調這一轉變，2025年4月發布的dvm360報告《美國農業部宣布撥款1億美元用於禽流感防控》指出，美國農業部已撥款高達1億美元，用於支持開發與DIVA檢測通訊協定兼容的疫苗和治療方法，以保護家禽供應。

The Global Poultry Diagnostics Market is projected to expand from USD 534.10 Million in 2025 to USD 896.23 Million by 2031, achieving a CAGR of 9.01%. This sector encompasses specialized reagents, test kits, and instruments designed to detect pathogens and monitor avian health. Growth is primarily driven by the rising global demand for animal-derived protein, which necessitates strict disease surveillance to maintain food security and supply chain stability. Additionally, the growing threat of transboundary zoonotic diseases obliges producers to implement rigorous testing protocols to satisfy international trade regulations and animal welfare standards. The scale of this requirement is significant; for instance, the National Chicken Council reported that the United States produced over 9.4 billion broiler chickens in 2024, highlighting the massive operations that require constant monitoring to prevent disease outbreaks.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 534.10 Million
Market Size 2031	USD 896.23 Million
CAGR 2026-2031	9.01%
Fastest Growing Segment	ELISA
Largest Market	North America

Despite this positive outlook, the market faces significant hurdles due to the high operational costs associated with advanced diagnostic technologies. For small-scale producers in developing regions, the financial strain of establishing sophisticated molecular testing infrastructure often exceeds the immediate economic returns. This cost barrier creates a disparity in accessibility, leaving vulnerabilities in global disease management. Consequently, these financial limitations may impede the widespread adoption and expansion of diagnostic solutions in price-sensitive markets, effectively slowing growth in these areas.

Market Driver

The rising global consumption of poultry meat and eggs is fundamentally transforming the diagnostics landscape, compelling producers to intensify operations to meet the demand for affordable protein. This rapid expansion requires strict health monitoring protocols to avoid supply chain disruptions and ensure flock productivity. As production density increases, reliance on diagnostic testing becomes essential for maintaining herd health and optimizing yield. The OECD-FAO Agricultural Outlook from July 2024 projects that global poultry meat consumption will reach 160 million metric tons by 2033, emphasizing the sustained pressure on producers. To meet this demand, the industry operates on a massive scale; the USDA forecast in April 2024 that global chicken meat production would reach 103.3 million tons for the year, a volume that directly fuels the need for diagnostic solutions.

Simultaneously, the increasing prevalence of zoonotic and infectious avian diseases acts as a critical catalyst for adopting advanced detection methods. Pathogens pose a threat to animal welfare and inflict severe financial damage, driving stakeholders to invest in rapid and accurate testing infrastructure. Effective diagnostics serve as the primary defense against outbreaks that could lead to mass culling and trade restrictions. The economic impact is substantial; the National Library of Medicine estimated in 2024 that the parasitic disease Coccidiosis alone costs the industry between $2.4 billion and $3 billion annually. Such financial risks underscore the priority placed on early detection technologies to contain outbreaks before they escalate into regional crises.

Market Challenge

The Global Poultry Diagnostics Market faces a significant barrier to growth due to the high capital and operational costs required for automated platforms and advanced molecular testing. These methods necessitate expensive instrumentation, specialized reagents, and skilled personnel, creating a cost structure that is often unsustainable for small and medium-scale producers. In emerging economies where profit margins are tight, the expense of implementing rigorous testing protocols often outweighs the perceived immediate value, forcing farmers to rely on less accurate, traditional observation methods rather than investing in precise diagnostic tools.

This economic constraint directly limits the Total Addressable Market for diagnostic manufacturers, effectively stalling expansion in regions that otherwise possess high volume potential. By restricting adoption to wealthy, industrialized nations, the market fails to address the critical need for disease management in price-sensitive areas. The magnitude of this missed opportunity is highlighted by the global prevalence of transboundary diseases; the World Organisation for Animal Health noted in 2024 that highly pathogenic avian influenza affected 82 countries and territories worldwide. Despite the widespread reach of these pathogens, prohibitive infrastructure costs prevent the diagnostics market from achieving proportional growth in these affected territories.

Market Trends

The integration of Artificial Intelligence for predictive disease modeling is revolutionizing the sector by shifting the focus from reactive diagnosis to proactive health management. Advanced algorithms are now capable of analyzing continuous data streams from barn environments, such as water consumption and vocalization acoustics, to detect subtle physiological anomalies before clinical signs appear. This capability enables producers to intervene days earlier than traditional methods allow, significantly reducing outbreak severity and antibiotic reliance. For example, a WATTPoultry article from October 2025 titled 'New take on water data could boost poultry disease detection' reported that Optifarm's AI analysis of drinking patterns can identify innate immune system responses with over 91% certainty, offering a critical early warning system without requiring new hardware.

Concurrently, the implementation of DIVA (Differentiating Infected from Vaccinated Animals) strategies is gaining momentum as the industry adapts to the endemic nature of Highly Pathogenic Avian Influenza (HPAI). As traditional mass-culling becomes economically unsustainable, there is a strategic pivot toward vaccination, which necessitates companion diagnostics to distinguish vaccinated birds from those infected with the wild-type virus to maintain trade eligibility. Highlighting this shift, a dvm360 report from April 2025 titled 'USDA announces $100M funding opportunity for avian influenza solutions' noted that the USDA allocated up to $100 million to support the development of vaccines and therapeutics compatible with DIVA testing protocols to safeguard the poultry supply.

Key Market Players

Zoetis Services LLC
QIAGEN N.V.
BioChek BV
Bioneer Corporation
Thermo Fisher Scientific Inc.
MEGACOR Diagnostik GmbH
IDEXX Laboratories, Inc.
Randox Laboratories Ltd.
INDICAL Bioscience GmbH
Heska Corporation

Report Scope

In this report, the Global Poultry Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Diagnostics Market, By Test Type

ELISA
PCR

Poultry Diagnostics Market, By Disease Type

Avian Salmonellosis
Avian Influenza
Newcastle Disease
Others

Poultry Diagnostics Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Diagnostics Market.

Available Customizations:

Global Poultry Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Poultry Diagnostics Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Test Type (ELISA, PCR)
- 5.2.2. By Disease Type (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Poultry Diagnostics Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Test Type
- 6.2.2. By Disease Type
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Poultry Diagnostics Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Test Type
    - 6.3.1.2.2. By Disease Type
- 6.3.2. Canada Poultry Diagnostics Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Test Type
    - 6.3.2.2.2. By Disease Type
- 6.3.3. Mexico Poultry Diagnostics Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Test Type
    - 6.3.3.2.2. By Disease Type

7. Europe Poultry Diagnostics Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Test Type
- 7.2.2. By Disease Type
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Poultry Diagnostics Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Test Type
    - 7.3.1.2.2. By Disease Type
- 7.3.2. France Poultry Diagnostics Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Test Type
    - 7.3.2.2.2. By Disease Type
- 7.3.3. United Kingdom Poultry Diagnostics Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Test Type
    - 7.3.3.2.2. By Disease Type
- 7.3.4. Italy Poultry Diagnostics Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Test Type
    - 7.3.4.2.2. By Disease Type
- 7.3.5. Spain Poultry Diagnostics Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Test Type
    - 7.3.5.2.2. By Disease Type

8. Asia Pacific Poultry Diagnostics Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Test Type
- 8.2.2. By Disease Type
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Poultry Diagnostics Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Test Type
    - 8.3.1.2.2. By Disease Type
- 8.3.2. India Poultry Diagnostics Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Test Type
    - 8.3.2.2.2. By Disease Type
- 8.3.3. Japan Poultry Diagnostics Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Test Type
    - 8.3.3.2.2. By Disease Type
- 8.3.4. South Korea Poultry Diagnostics Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Test Type
    - 8.3.4.2.2. By Disease Type
- 8.3.5. Australia Poultry Diagnostics Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Test Type
    - 8.3.5.2.2. By Disease Type

9. Middle East & Africa Poultry Diagnostics Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Test Type
- 9.2.2. By Disease Type
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Poultry Diagnostics Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Test Type
    - 9.3.1.2.2. By Disease Type
- 9.3.2. UAE Poultry Diagnostics Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Test Type
    - 9.3.2.2.2. By Disease Type
- 9.3.3. South Africa Poultry Diagnostics Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Test Type
    - 9.3.3.2.2. By Disease Type

10. South America Poultry Diagnostics Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Test Type
- 10.2.2. By Disease Type
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Poultry Diagnostics Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Test Type
    - 10.3.1.2.2. By Disease Type
- 10.3.2. Colombia Poultry Diagnostics Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Test Type
    - 10.3.2.2.2. By Disease Type
- 10.3.3. Argentina Poultry Diagnostics Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Test Type
    - 10.3.3.2.2. By Disease Type

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Poultry Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Zoetis Services LLC
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. QIAGEN N.V.
15.3. BioChek BV
15.4. Bioneer Corporation
15.5. Thermo Fisher Scientific Inc.
15.6. MEGACOR Diagnostik GmbH
15.7. IDEXX Laboratories, Inc.
15.8. Randox Laboratories Ltd.
15.9. INDICAL Bioscience GmbH
15.10. Heska Corporation